|
||
Articles |








Department of Physiology and the
Department of Neurology, University of Minnesota, Minneapolis, Minnesota 55455; the || Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030; the ¶ Department of Surgery, North Shore University Hospital–New York University Medical School, Manhasset, New York 11030; the ** Department of Experimental Pathology and Laboratory Medicine, Albany Medical College, Albany, New York 12208; and the 
Division of Biology and Human Genetics, Department of Medicine, and the 
Department of Emergency Medicine, North Shore University Hospital–New York University Medical School, Manhasset, New York 11030; and the ||||Laboratory of Organic Chemistry, The Picower Institute for Medical Research, Manhasset, New York 11030
To elucidate endogenous mechanisms underlying cerebral damage during ischemia, brain polyamine oxidase activity was measured in rats subjected to permanent occlusion of the middle cerebral artery. Brain polyamine oxidase activity was increased significantly within 2 h after the onset of ischemia in brain homogenates (15.8 ± 0.9 nmol/h/mg protein) as compared with homogenates prepared from the normally perfused contralateral side (7.4 ± 0.5 nmol/h/mg protein) (P <0.05). The major catabolic products of polyamine oxidase are putrescine and 3-aminopropanal. Although 3-aminopropanal is a potent cytotoxin, essential information was previously lacking on whether 3-aminopropanal is produced during cerebral ischemia. We now report that 3-aminopropanal accumulates in the ischemic brain within 2 h after permanent forebrain ischemia in rats. Cytotoxic levels of 3-aminopropanal are achieved before the onset of significant cerebral cell damage, and increase in a time-dependent manner with spreading neuronal and glial cell death. Glial cell cultures exposed to 3-aminopropanal undergo apoptosis (LD50 = 160 µM), whereas neurons are killed by necrotic mechanisms (LD50 = 90 µM). The tetrapeptide caspase 1 inhibitor (Ac-YVAD-CMK) prevents 3-aminopropanal–mediated apoptosis in glial cells. Finally, treatment of rats with two structurally distinct inhibitors of polyamine oxidase (aminoguanidine and chloroquine) attenuates brain polyamine oxidase activity, prevents the production of 3-aminopropanal, and significantly protects against the development of ischemic brain damage in vivo. Considered together, these results indicate that polyamine oxidase–derived 3-aminopropanal is a mediator of the brain damaging sequelae of cerebral ischemia, which can be therapeutically modulated.
Key Words: stroke infarction spermine apoptosis caspase
Abbreviations used: EIMS, Electrospray ionization mass spectroscopy; iNOS, inducible nitric oxide synthase; NMDA, N-methyl-D-aspartate; NMR, nuclear magnetic resonance; PAO, polyamine oxidase; PCA, perchloric acid; TTC, 2,3,5-triphenyltetrazolium chloride; TUNEL, Tdt-mediated dUTP–biotin nick-end labeling.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| TABLE OF CONTENTS |
|